- Tytuł:
- PORT: A Randomized, Cross-Over, Phase 2 Study of Melflufen Peripheral Versus Central Intravenous Administration in Patients With Relapsed/Refractory Multiple Myeloma
- Autorzy:
- Źródło:
- In Clinical Lymphoma, Myeloma and Leukemia February 2024
Czasopismo naukowe